Evidence map›Paper›PMID 32333623›Full record

ArticleThe oncologist2020

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements.

Ashley Woolmore, Dirk Arnold, Jean-Yves Blay, Christian Buske, Alfredo Carrato, Winald Gerritsen, Marc Peeters, Jesus Garcia-Foncillas, David Kerr

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The oncologist, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Pilot study of a European oncology regimen reference library and matching algorithm.European journal of hospital pharmacy : science and practice · 2023
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ashley WoolmoreIQVIA, London, United Kingdom.ORCID https://orcid.org/0000-0001-5549-0471
Dirk ArnoldAsklepios Tumorzentrum Hamburg, AK Altona, Hamburg, Germany.
Jean-Yves BlayCentre Léon Bérard, Lyon, France.
Christian BuskeComprehensive Cancer Center, University Hospital Ulm, Ulm, Germany.
Alfredo CarratoRamón y Cajal University Hospital, Alcala University, IRYCIS, CIBERONC, Madrid, Spain.
Winald GerritsenRadboud University Medical Center, Nijmegen, The Netherlands.
Marc PeetersCenter for Oncological Research, University of Antwerp, and Antwerp University Hospital, Edegem, Belgium.
Jesus Garcia-FoncillasUniversity Cancer Institute and the Department of Oncology, University Hospital Fundacion Jimenez Diaz, Madrid, Spain.
David KerrJohn Radcliffe Hospital, Nuffield Division of Clinical Laboratory Sciences, Oxford, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Medical OncologyHumans

Identifiers

PMID32333623
PMCPMC7543245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.